Beskrivelse
Krav
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2009.04.30, US 174124 P
BROWN BRIAN D ET AL: "Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state" NATURE BIOTECHNOLOGY, vol. 25, no. 12, 16 November 2007 (2007-11-16), pages 1457-1467, XP002471752 ISSN: 1087-0156 cited in the application (B1)
CARTIER NATHALIE ET AL: "Hematopoietic stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy." CURRENT OPINION IN MOLECULAR THERAPEUTICS, vol. 10, no. 5, October 2008 (2008-10), pages 471-478, XP008127749 ISSN: 1464-8431 (B1)
G. ESCOBAR ET AL: "Genetic Engineering of Hematopoiesis for Targeted IFN- Delivery Inhibits Breast Cancer Progression", SCIENCE TRANSLATIONAL MEDICINE, vol. 6, no. 217, 1 January 2014 (2014-01-01), pages 217ra3-217ra3, XP055492866, US ISSN: 1946-6234, DOI: 10.1126/scitranslmed.3006353 (B1)
GARZON RAMIRO ET AL: "MicroRNA fingerprints during human megakaryocytopoiesis" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 103, no. 13, 28 March 2006 (2006-03-28), pages 5078-5083, XP002465978 ISSN: 0027-8424 (B1)
GENTNER BERNHARD ET AL: "Characterization of Hematopoietic Stem Cell Specific microRNA: From Physiologic Function to Gene Therapy Applications" MOLECULAR THERAPY, vol. 17, no. Suppl. 1, May 2009 (2009-05), page S20, XP008127618 ISSN: 1525-0016 & 12TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE THERAPY; SAN DIEGO, CA, USA; MAY 27 -30, 2009 (B1)
GENTNER ET AL: "Exploiting microRNA expression profiles for lineage- and differentiation state-specific transgene expression in hematopoietic, neural and embryonic stem cells" BLOOD CELLS, MOLECULES AND DISEASES, vol. 40, no. 2, 12 February 2008 (2008-02-12), page 267, XP022477840 ISSN: 1079-9796 (B1)
WO-A1-2006/128245 (B1)
LECHMAN ERIC R ET AL: "High Levels of MicroRNA-126 Bioactivity Specify the LSC Compartment in AML" BLOOD, vol. 112, no. 11, November 2008 (2008-11), page 193, XP008127737 ISSN: 0006-4971 & 50TH ANNUAL MEETING OF THE AMERICAN- SOCIETY-OF-HEMATOLOGY; SAN FRANCISCO, CA, USA; DECEMBER 06 -09, 2008 (B1)
M. CATARINELLA ET AL: "IFN gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment", EMBO MOLECULAR MEDICINE, vol. 8, no. 2, 1 February 2016 (2016-02-01), pages 155-170, XP055492868, Weinheim ISSN: 1757-4676, DOI: 10.15252/emmm.201505395 (B1)
MARIA CHIRIACO ET AL: "Dual-regulated Lentiviral Vector for Gene Therapy of X-linked Chronic Granulomatosis", MOLECULAR THERAPY : THE JOURNAL OF THE AMERICAN SOCIETY OF GENE THERAPY, vol. 22, no. 8, 1 August 2014 (2014-08-01) , pages 1472-1483, XP055492876, US ISSN: 1525-0016, DOI: 10.1038/mt.2014.87 (B1)
PAPAPETROU EIRINI P ET AL: "microRNA-mediated gene regulation effectively restricts in vivo transgene expression in hematopoietic stem cell progeny" BLOOD, vol. 110, no. 11, Part 1, November 2007 (2007-11), pages 64A-65A, XP008127620 ISSN: 0006-4971 & 49TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ATLANTA, GA, USA; DECEMBER 08 -11, 2007 (B1)
RYSER MARTIN F ET AL: "Gene therapy for chronic granulomatous disease." EXPERT OPINION ON BIOLOGICAL THERAPY, vol. 7, no. 12, December 2007 (2007-12), pages 1799-1809, XP008127764 ISSN: 1744-7682 (B1)
JORDAN ET AL: "The leukemic stem cell", BEST PRACTICE & RESEARCH CLINICAL HAEMATO, ELSEVIER, AMSTERDAM, NL, vol. 20, no. 1, 28 February 2007 (2007-02-28), pages 13-18, XP005906162, ISSN: 1521-6926, DOI: 10.1016/J.BEHA.2006.10.005 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP2424571)
|
Utgående
EP Registreringsbrev (3210) (PTEP2424571)
|
Utgående
EP Registreringsbrev (3210) (PTEP2424571)
|
Innkommende
Korrespondanse (Hovedbrev inn)
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP2424571)
|
Innkommende, AR373059550
Korrespondanse (Hovedbrev inn)
|
Utgående
EP defect letter
|
Innkommende, AR371695444
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 16. avg. år (EP) expand_more expand_less | 2025.04.09 | 6760,0 | CLARIVATE IP SERVICES LIMITED | Betalt og godkjent |
Årsavgift 16. avg. år (EP)
6760,0 = 1 X 6760,0
En ordre på saken er opprettet av: Renewals Team (08.04.2025 14:01:54): Betalt |
||||
Årsavgift 15. avg. år (EP) | 2024.04.25 | 6310 | CLARIVATE IP SERVICES LIMITED | Betalt og godkjent |
Årsavgift 14. avg. år (EP) | 2023.04.25 | 4500 | ENVOY INTERNATIONAL LIMITED | Betalt og godkjent |
Årsavgift 13. avg. år (EP) | 2022.04.22 | 4200 | ENVOY INTERNATIONAL LIMITED | Betalt og godkjent |
Årsavgift 12. avg. år (EP) | 2021.04.23 | 3850 | ENVOY INTERNATIONAL LIMITED | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2020.06.04 | 3500 | TANDBERG INNOVATION AS | Betalt og godkjent |
32006666 expand_more expand_less | 2020.05.20 | 5500 | TANDBERG INNOVATION AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|